In the News
AJMC: Dr. Ruben Mesa outlines the quality of life impact of myelofibrosis
January 27, 2020
Ruben Mesa, MD, director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the impact myelofibrosis has on patients’ quality of life while at the American Society of Hematology conference.
News 4: Treatment for veterans suffering from PTSD following Hurricane Harvey devastation
January 27, 2020
UT Health San Antonio has launched an intensive out-patient program for veterans suffering from post-traumatic stress disorder following the devastation caused by Hurricane Harvey.
Cure Today: Addressing the symptom burden of patients with MPN
January 24, 2020
Dr. Robyn Scherber,created an assessment form to help patients with myeloproliferative neoplasms explain their symptoms to their care team.
San Antonio Express-News: UT Health San Antonio and UTSA agreement offers shorter path for in-demand medical career
January 23, 2020
UT Health San Antonio and The University of Texas at San Antonio (UTSA) are starting a fast-track degree program for future respiratory therapists, a job that’s increasingly in demand.
KSAT 12: Infectious disease specialist says there’s no need to panic about new strain of coronavirus
January 23, 2020
Dr. Jason Bowling, an associate professor of infectious diseases at UT Health San Antonio, tells KSAT’s Jessie Degollado that the U.S. has “no need to panic right now” amid international efforts to contain the coronavirus, a respiratory disease, that began in China. There is one coronavirus patient in the U.S. who is recovering in Seattle. […]
Targeted Oncology: Expert highlights benefits of Fedratinib in subgroup of patients with myelofibrosis
January 22, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discussed the benefits of Fedratinib (Inrebic) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis. Read the full story